Takeda, Sanofi To Partner For Diabetes Drug Sales In China
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical and Sanofi Group plan a partnership aimed at increasing lifestyle drug sales in China, beginning this fiscal year with the Japan drug maker's Nesina (alogliptin) diabetes treatment.